Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 120.19
   
  • Change Today:
    $-3.21
  • 52 Week High: $124.08
  • 52 Week Low: $87.75
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 3,483,887
  • Market Cap: $149,757m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 120.19
Change Today $ -3.21
% Change -2.60 %
52 Week High $124.08
52 Week Low $87.75
Volume 3,483,887
Shares Issued 1,246.00m
Market Cap $149,757m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Nov-2025

Time Volume / Share Price
12:19 100 @ $120.19
12:19 100 @ $120.19
12:19 100 @ $120.17
12:19 100 @ $120.17
12:19 100 @ $120.17

Top of Page